After finishing at $9.58 in the prior trading day, Sana Biotechnology Inc (NASDAQ: SANA) closed at $9.50, down -0.84%. In other words, the price has decreased by -$0.08 from its previous closing price. On the day, 1402021 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of SANA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.31 and its Current Ratio is at 3.31. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.32.
On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.
On September 05, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $8.Citigroup initiated its Buy rating on September 05, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 08 ’24 when NELSEN ROBERT bought 1,818,181 shares for $5.50 per share. The transaction valued at 9,999,996 led to the insider holds 12,446,022 shares of the business.
ARCH Venture Fund X, L.P. bought 1,818,181 shares of SANA for $9,999,996 on Feb 08 ’24. The 10% Owner now owns 12,446,022 shares after completing the transaction at $5.50 per share. On Feb 08 ’24, another insider, CRANDELL KEITH, who serves as the 10% Owner of the company, bought 1,818,181 shares for $5.50 each. As a result, the insider paid 9,999,996 and bolstered with 12,446,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 2.09B and an Enterprise Value of 1.99B.
Stock Price History:
Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is 6.79, while the 200-Day Moving Average is calculated to be 5.33.
Shares Statistics:
The stock has traded on average 3.59M shares per day over the past 3-months and 3.14M shares per day over the last 10 days, according to various share statistics. A total of 197.86M shares are outstanding, with a floating share count of 108.92M. Insiders hold about 50.59% of the company’s shares, while institutions hold 40.61% stake in the company. Shares short for SANA as of Feb 15, 2024 were 22.08M with a Short Ratio of 6.15, compared to 20.17M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.08% and a Short% of Float of 18.43%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.32 for the current quarter, with a high estimate of -$0.25 and a low estimate of -$0.43, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.22 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$0.93 and -$1.76 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$1.37, with 4 analysts recommending between -$0.92 and -$1.97.
